What is it about?

This work describes the crystal structure determination by using X-ray powder diffraction data and an ab initio simulated annealing algorithm followed by a Rietveld refinement. Rifampicin is a first-line drug used in the treatment of tuberculosis. Several polymorphs are known to date, all of them describing solvates of rifampicin.

Featured Image

Why is it important?

We determine the crystal structure of a stable form of rifampicin (form I). From now on, the identification of this polymorph in raw samples of rifampicin can be identified and, most importantly, quantified.

Read the Original

This page is a summary of: Structural characterization of form I of anhydrous rifampicin, CrystEngComm, January 2014, Royal Society of Chemistry,
DOI: 10.1039/c4ce01157k.
You can read the full text:

Read

Resources

Contributors

The following have contributed to this page